Cryo-Cell
CCEL
Operating Margin for Cryo-Cell (CCEL)
Operating Margin as of May 2024 (TTM): 9.04%
According to Cryo-Cell's latest financial reports and stock price the company's current Operating Margin is 9.04%. At the end of 2021 the company had an Operating Margin of 9.04%.
Operating Margin history for Cryo-Cell from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | 9.04% | -44.12% |
| 2020 | 16.18% | 51.78% |
| 2019 | 10.66% | -13.91% |
| 2018 | 12.38% | -13.27% |
| 2017 | 14.28% | -233.12% |
| 2016 | -10.72% | -338.21% |
| 2015 | 4.50% | 33.81% |
| 2014 | 3.36% | 224.37% |
| 2013 | 1.04% | -104.22% |
| 2012 | -24.60% | 159.79% |
| 2011 | -9.47% | -193.8% |
| 2010 | 10.09% | 6.57% |
| 2009 | 9.47% | -315.23% |
| 2008 | -4.40% | -84.65% |
| 2007 | -28.67% | 80.6% |
| 2006 | -15.87% | -305.33% |
| 2005 | 7.73% | -68.73% |
| 2004 | 24.72% | -124.82% |
| 2003 | -99.62% | 36.39% |
| 2002 | -73.04% | 749.06% |
| 2001 | -8.60% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Omnicell
OMCL | -2.84% | -131.42% | 🇺🇸 USA |
 Global Cord Blood CORBF | 48.96% | 441.59% | 🇭🇰 Hong Kong |
 CorVel Corporation
CRVL | 12.12% | 34.07% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.